Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tercica Inc (TRCA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Tercica Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1262175.
Total stock buying since 2005: $85,350,466.
Total stock sales since 2005: $7,461,084.
Total stock option exercises since 2005: $62,847.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 410,831 | $3,664,612 | 0 | $0 | 0 | $0 |
| 2007 | 519,101 | $2,922,538 | 0 | $0 | 0 | $0 |
| 2006 | 12,542,245 | $77,369,526 | 0 | $0 | 62,847 | $62,847 |
| 2005 | 211,000 | $1,393,790 | 609,678 | $7,461,084 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-07 | 410,831 | $3,664,612 | 0 | $0 | 0 | $0 |
| 2007-08 | 519,101 | $2,922,538 | 0 | $0 | 0 | $0 |
| 2006-10 | 12,527,245 | $77,293,101 | 0 | $0 | 0 | $0 |
| 2006-08 | 15,000 | $76,425 | 0 | $0 | 0 | $0 |
| 2006-02 | 0 | $0 | 0 | $0 | 62,847 | $62,847 |
| 2005-12 | 211,000 | $1,393,790 | 0 | $0 | 0 | $0 |
| 2005-09 | 0 | $0 | 609,678 | $7,461,084 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-07-22 | Ipsen, S.a. (10% Owner) | Buy | 410,831 | 8.92 | 3,664,612 |
| 2007-08-30 | Ipsen, S.a. (10% Owner) | Buy | 519,101 | 5.63 | 2,922,538 |
| 2006-10-13 | Suraypharm, Sas (10% Owner) | Buy | 12,527,245 | 6.17 | 77,293,101 |
| 2006-08-25 | Rosenfield Stephen (EVP- Legal Affairs; G.C. & Sec) | Buy | 15,000 | 5.09 | 76,425 |
| 2006-02-16 | Clark Ross G (CHIEF TECHNICAL OFFICER) | Option Ex | 62,847 | 1.00 | 62,847 |
| 2005-12-14 | Rosenfield Stephen (Senior V.P. of Legal) | Buy | 10,000 | 7.14 | 71,400 |
| 2005-12-13 | Rivera Christopher Eugene (Snr VP, Commercial O) | Buy | 1,000 | 6.59 | 6,590 |
| 2005-12-13 | Barkas Alexander E (Director) | Buy | 200,000 | 6.58 | 1,315,800 |
| 2005-09-07 | Henner Dennis (Director) | Sale | 8,400 | 12.00 | 100,800 |
| 2005-09-07 | Simon Nicholas J Iii (10% Owner) | Sale | 8,400 | 12.00 | 100,800 |
| 2005-09-07 | Mpm Bioventures Iii Qp Lp (10% Owner) | Sale | 8,400 | 12.00 | 100,800 |
| 2005-09-06 | Henner Dennis (Director) | Sale | 194,826 | 12.25 | 2,386,228 |
| 2005-09-06 | Simon Nicholas J Iii (10% Owner) | Sale | 194,826 | 12.25 | 2,386,228 |
| 2005-09-06 | Mpm Bioventures Iii Qp Lp (10% Owner) | Sale | 194,826 | 12.25 | 2,386,228 |
Insider trading activities including stock purchases, stock sales, and option exercises of TRCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tercica Inc (symbol TRCA, CIK number 1262175) see the Securities and Exchange Commission (SEC) website.